The Future of Cancer Genetics Is Here - Reversion Mutations in BRCA1/2 in Response to Therapy

About
Share
Copy link
Copying text was successful.
306
Presenter: Katherine Nathanson Pearl Basser Professor for BRCA-Related Research, University of Pennsylvania Abramson Cancer Center Philadelphia, PA, USA
Release Date: December 20, 2024
Congress: SABCS 2024
Area: Oncology | Breast Cancer
Description:

Katherine L. Nathanson, MD discusses reversion mutations in BRCA1/2 in response to therapy at San Antonio Breast Cancer Symposium 2024.